EXD3 and type 2 diabetes mellitus: Although the findings did not replicate in the subset of FinnDiane study participants genotyped with the same array, its validity was supported by evidence of replication in UK Biobank individuals with T2D, the Million Veteran Program, and other genetic databases, as well as associations of other EXD3 variants in T1D replication cohorts.